Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency

Erstveröffentlichung
2020Authors
Werner-Klein, Melanie
Grujovic, Ana
Irlbeck, Christoph
Hoffmann, Martin
Koerkel-Qu, Huiqin
Wissenschaftlicher Artikel
Published in
Nature Communications ; 11 (2020), 1. - Art.-Nr. 4977. - ISSN 2041-1723
Link to publication
https://dx.doi.org/10.1038/s41467-020-18701-4Institutions
UKU. Klinik für Frauenheilkunde und GeburtshilfeSubject headings
[Free subject headings]: DISSEMINATED TUMOR-CELLS | COMPARATIVE GENOMIC HYBRIDIZATION | METASTATIC BREAST-CANCER | BONE-MARROW | IN-VIVO | EARLY DISSEMINATION | SOLUBLE GP130 | STEM-CELLS | RECEPTOR | IL-6[DDC subject group]: DDC 610 / Medicine & health